Startups
A globally operated biotech dedicated to discovering and developing fully engineered circular RNA therapeutics
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 26, 2024 | RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation | PRINCETON, N.J., Oct. 26, 2024 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics, announced that the US Food and Drug Ad... |
Reviews 0
FAQ about RiboX Therapeutics
What has the press written about RiboX Therapeutics?
Parsers VC has collected 2 articles mentioning RiboX Therapeutics, among them “RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia a...” (Oct 26, 2024).
Is RiboX Therapeutics still active?
Yes, RiboX Therapeutics is active; its latest activity on Parsers VC dates from Jul 10, 2026.